Imodium

Loperamide Hydrochloride, the active ingredient in Imodium, is an antidiarrheal presented as an oral tablet for oral use. It reduces the frequency of loose stools in adults and children suffering from acute or chronic diarrheal conditions.

GNH USA supplies Imodium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the procurement process.

Imodium (loperamide) acts on the gastrointestinal tract to control excessive bowel movements associated with diarrheal disorders.

Acute diarrhea: reduces stool frequency and improves consistency. Chronic diarrhea: helps maintain regularity and reduces urgency. Irritable bowel syndrome with diarrhea: alleviates loose stools and abdominal discomfort.

Loperamide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Constipation: hard stools or difficulty passing stool. - Abdominal cramps: mild to moderate cramping sensations. - Nausea: feeling of queasiness. - Dizziness: light‑headed sensation. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe constipation: risk of bowel obstruction. - Ileus: paralytic intestinal blockage. - Toxic megacolon: rapid colon dilation. - Cardiac arrhythmias: irregular heart rhythm. - Allergic reactions: rash, itching, swelling.

When using Imodium, consider the following precautions to ensure safe and effective treatment. - Do not exceed recommended dose: follow prescriber or label instructions to avoid constipation. - Use with caution in elderly: slower gastrointestinal motility may increase risk of adverse effects. - Avoid in patients with bacterial enterocolitis: may retain toxins. - Contraindicated in known hypersensitivity to loperamide: discontinue if reaction occurs. - Monitor for signs of dehydration: maintain adequate fluid intake. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Loperamide can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase loperamide plasma levels and risk of cardiac toxicity. - P-glycoprotein inhibitors (e.g., quinidine, ritonavir): can raise systemic exposure, leading to central opioid effects.

Moderate Interactions (Monitor Closely): - Antidiarrheal agents containing diphenoxylate: additive opioid effect may cause excessive constipation. - Anticholinergic drugs: may enhance reduced gut motility. - Certain antidepressants (e.g., amitriptyline): potential for increased QT prolongation. - Opioid analgesics: may potentiate central opioid effects if blood‑brain barrier is compromised.